21
Jun 2017
Blood test targets advanced prostate cancer drug treatment
Prostate cancer is the most common cancer amongst men in the UK, with over 46,000 diagnosed with the disease each year. A blood test has been developed to identify which advanced patients would benefit from a new drug treatment. The test, which identifies cancer DNA in the blood, enables doctors to check whether precision drugs…
